Summary

Persistence Market Research has recently released a comprehensive report on the worldwide market for antibody discovery. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global antibody discovery market from 2024 to 2031.

Key Insights:

• Antibody Discovery Market Size (2024E): USD 8.2 Billion
• Projected Market Value (2031F): USD 14.9 Billion
• Global Market Growth Rate (CAGR 2024 to 2031): 8.9%

Antibody Discovery Market - Report Scope:

Antibody discovery plays a crucial role in the development of therapeutic and diagnostic solutions for a variety of diseases, including cancer, autoimmune disorders, and infectious diseases. This process involves identifying and generating monoclonal and polyclonal antibodies that can specifically target antigens. The antibody discovery market serves pharmaceutical companies, biotechnology firms, and research institutions, offering a range of technologies, including phage display, hybridoma technology, and next-generation sequencing.

Market Growth Drivers:

The global antibody discovery market is propelled by several key factors, including the rising prevalence of chronic diseases, such as cancer and autoimmune disorders, which drives the demand for targeted therapies. Advances in technology, such as high-throughput screening and artificial intelligence, enhance the efficiency and accuracy of antibody discovery, promoting market growth. Additionally, increasing investments in biopharmaceutical research and development, along with favorable regulatory frameworks, support the expansion of the antibody discovery market.

Market Restraints:

Despite promising growth prospects, the antibody discovery market faces challenges related to high costs and complex processes involved in antibody development. Regulatory hurdles and stringent quality control standards also pose significant barriers. Furthermore, competition from alternative therapies, such as small molecules and gene therapies, can affect market dynamics. Addressing these challenges requires continued innovation and collaboration among industry stakeholders to streamline development processes and reduce costs.

Market Opportunities:

The antibody discovery market presents significant growth opportunities driven by technological innovations, personalized medicine trends, and expanding applications. The integration of advanced technologies, such as single-cell analysis and CRISPR, enhances the precision of antibody discovery and broadens therapeutic applications. Additionally, the growing focus on personalized medicine and targeted therapies creates new avenues for market players. Strategic partnerships, investment in research and development, and the introduction of cost-effective solutions are essential to capitalize on emerging opportunities and sustain market leadership.

Competitive Intelligence and Business Strategy:

Leading players in the global antibody discovery market, including Abcam plc, Bio-Rad Laboratories, and GenScript Biotech Corporation, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced antibody discovery solutions, including novel screening platforms and high-throughput technologies, catering to diverse research and clinical needs. Collaborations with pharmaceutical companies, research institutions, and regulatory agencies facilitate market access and promote technology adoption. Moreover, emphasis on clinical research, evidence-based practice, and patient-specific solutions fosters market growth and enhances therapeutic outcomes in the rapidly evolving antibody discovery landscape.

Key Companies Profiled:

• Alcami Corporation, Inc.
• BASF SE
• Bioduro-Sundia
• Bruker
• Cambrex Corporation
• Croda International Plc
• Aragen Life Sciences Pvt. Ltd
• Eurofins DiscoverX Corporation
• NanoCellect Biomedical
• Sartorius AG

Antibody Discovery Market Research Segmentation

By Method:
• Phage Display
• Hybridoma
• Others

By Antibody Type:
• Humanized Antibody
• Human Antibody
• Chimeric Antibody
• Murine Antibody

By End-use:
• Pharmaceutical and Biotechnology industry
• Research laboratory
• Academic laboratory

By Region:
• North America
• Europe
• East Asia
• South Asia & Oceania
• Latin America
• Middle East & Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Antibody Discovery Market Snapshot, 2024-2031
1.2. Market Opportunity Assessment, 2024-2031, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Method Lifecycle Analysis
2.4. Antibody Discovery Market: Value Chain
2.4.1. List of Raw Material Supplier
2.4.2. List of Manufacturers
2.4.3. List of Distributors
2.4.4. List of Applications
2.4.5. Profitability Analysis
2.5. Porter Five Force's Analysis
2.6. Geopolitical Tensions: Market Impact
2.7. Macro-Economic Factors
2.7.1. Global Sectorial Outlook
2.7.2. Global GDP Growth Outlook
2.7.3. Global Parent Market Overview
2.8. Forecast Factors - Relevance and Impact
2.9. Regulatory and Technology Landscape
3. Global Antibody Discovery Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
3.1. Key Highlights
3.1.1. Market Volume (Units) Projections
3.1.2. Market Size and Y-o-Y Growth
3.1.3. Absolute $ Opportunity
3.2. Market Size (US$ Bn) Analysis and Forecast
3.2.1. Historical Market Size Analysis, 2019-2023
3.2.2. Current Market Size Forecast, 2024-2031
3.3. Global Antibody Discovery Market Outlook: Method
3.3.1. Introduction / Key Findings
3.3.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Method, 2019-2023
3.3.3. Current Market Size (US$ Bn) and Volume (Units) Forecast By Method, 2024-2031
3.3.3.1. Phage Display
3.3.3.2. Hybridoma
3.3.3.3. Others
3.4. Market Attractiveness Analysis: Method
3.5. Global Antibody Discovery Market Outlook: Antibody Type
3.5.1. Introduction / Key Findings
3.5.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Antibody Type, 2019-2023
3.5.3. Current Market Size (US$ Bn) and Volume (Units) Forecast By Antibody Type, 2024-2031
3.5.3.1. Humanized Antibody
3.5.3.2. Human Antibody
3.5.3.3. Chimeric Antibody
3.5.3.4. Murine Antibody
3.6. Market Attractiveness Analysis: Antibody Type
3.7. Global Antibody Discovery Market Outlook: End User
3.7.1. Introduction / Key Findings
3.7.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By End User, 2019-2023
3.7.3. Current Market Size (US$ Bn) and Volume (Units) Forecast By End User, 2024-2031
3.7.3.1. Pharmaceutical and Biotechnology industry
3.7.3.2. Research laboratory
3.7.3.3. Academic laboratory
3.8. Market Attractiveness Analysis: End User
4. Global Antibody Discovery Market Outlook: Region
4.1. Key Highlights
4.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Region, 2019-2023
4.3. Current Market Size (US$ Bn) and Volume (Units) Forecast By Region, 2024-2031
4.3.1. North America
4.3.2. Europe
4.3.3. East Asia
4.3.4. South Asia & Pacific
4.3.5. Latin America
4.3.6. Middle East & Africa (MEA)
4.4. Market Attractiveness Analysis: Region
5. North America Antibody Discovery Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
5.1. Key Highlights
5.2. Pricing Analysis
5.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market, 2019-2023
5.3.1. By Country
5.3.2. By Method
5.3.3. By Antibody Type
5.3.4. By End User
5.4. Current Market Size (US$ Bn) and Volume (Units) Forecast By Country, 2024-2031
5.4.1. U.S.
5.4.2. Canada
5.5. Current Market Size (US$ Bn) and Volume (Units) Forecast By Method, 2024-2031
5.5.1. Phage Display
5.5.2. Hybridoma
5.5.3. Others
5.6. Current Market Size (US$ Bn) and Volume (Units) Forecast By Antibody Type, 2024-2031
5.6.1. Humanized Antibody
5.6.2. Human Antibody
5.6.3. Chimeric Antibody
5.6.4. Murine Antibody
5.7. Current Market Size (US$ Bn) and Volume (Units) Forecast By End User, 2024-2031
5.7.1. Pharmaceutical and Biotechnology industry
5.7.2. Research laboratory
5.7.3. Academic laboratory
5.8. Market Attractiveness Analysis
6. Europe Antibody Discovery Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
6.1. Key Highlights
6.2. Pricing Analysis
6.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market, 2019-2023
6.3.1. By Country
6.3.2. By Method
6.3.3. By Antibody Type
6.3.4. By End User
6.4. Current Market Size (US$ Bn) and Volume (Units) Forecast By Country, 2024-2031
6.4.1. Germany
6.4.2. France
6.4.3. U.K.
6.4.4. Italy
6.4.5. Spain
6.4.6. Russia
6.4.7. Turkey
6.4.8. Rest of Europe
6.5. Current Market Size (US$ Bn) and Volume (Units) Forecast By Method, 2024-2031
6.5.1. Phage Display
6.5.2. Hybridoma
6.5.3. Others
6.6. Current Market Size (US$ Bn) and Volume (Units) Forecast By Antibody Type, 2024-2031
6.6.1. Humanized Antibody
6.6.2. Human Antibody
6.6.3. Chimeric Antibody
6.6.4. Murine Antibody
6.7. Current Market Size (US$ Bn) and Volume (Units) Forecast By End User, 2024-2031
6.7.1. Pharmaceutical and Biotechnology industry
6.7.2. Research laboratory
6.7.3. Academic laboratory
6.8. Market Attractiveness Analysis
7. East Asia Antibody Discovery Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market, 2019-2023
7.3.1. By Country
7.3.2. By Method
7.3.3. By Antibody Type
7.3.4. By End User
7.4. Current Market Size (US$ Bn) and Volume (Units) Forecast By Country, 2024-2031
7.4.1. China
7.4.2. Japan
7.4.3. South Korea
7.5. Current Market Size (US$ Bn) and Volume (Units) Forecast By Method, 2024-2031
7.5.1. Phage Display
7.5.2. Hybridoma
7.5.3. Others
7.6. Current Market Size (US$ Bn) and Volume (Units) Forecast By Antibody Type, 2024-2031
7.6.1. Humanized Antibody
7.6.2. Human Antibody
7.6.3. Chimeric Antibody
7.6.4. Murine Antibody
7.7. Current Market Size (US$ Bn) and Volume (Units) Forecast By End User, 2024-2031
7.7.1. Pharmaceutical and Biotechnology industry
7.7.2. Research laboratory
7.7.3. Academic laboratory
7.8. Market Attractiveness Analysis
8. South Asia & Oceania Antibody Discovery Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market, 2019-2023
8.3.1. By Country
8.3.2. By Method
8.3.3. By Antibody Type
8.3.4. By End User
8.4. Current Market Size (US$ Bn) and Volume (Units) Forecast By Country, 2024-2031
8.4.1. India
8.4.2. Southeast Asia
8.4.3. ANZ
8.4.4. Rest of South Asia & Oceania
8.5. Current Market Size (US$ Bn) and Volume (Units) Forecast By Method, 2024-2031
8.5.1. Phage Display
8.5.2. Hybridoma
8.5.3. Others
8.6. Current Market Size (US$ Bn) and Volume (Units) Forecast By Antibody Type, 2024-2031
8.6.1. Humanized Antibody
8.6.2. Human Antibody
8.6.3. Chimeric Antibody
8.6.4. Murine Antibody
8.7. Current Market Size (US$ Bn) and Volume (Units) Forecast By End User, 2024-2031
8.7.1. Pharmaceutical and Biotechnology industry
8.7.2. Research laboratory
8.7.3. Academic laboratory
8.8. Market Attractiveness Analysis
9. Latin America Antibody Discovery Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market, 2019-2023
9.3.1. By Country
9.3.2. By Method
9.3.3. By Antibody Type
9.3.4. By End User
9.4. Current Market Size (US$ Bn) and Volume (Units) Forecast By Country, 2024-2031
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Current Market Size (US$ Bn) and Volume (Units) Forecast By Method, 2024-2031
9.5.1. Phage Display
9.5.2. Hybridoma
9.5.3. Others
9.6. Current Market Size (US$ Bn) and Volume (Units) Forecast By Antibody Type, 2024-2031
9.6.1. Humanized Antibody
9.6.2. Human Antibody
9.6.3. Chimeric Antibody
9.6.4. Murine Antibody
9.7. Current Market Size (US$ Bn) and Volume (Units) Forecast By End User, 2024-2031
9.7.1. Pharmaceutical and Biotechnology industry
9.7.2. Research laboratory
9.7.3. Academic laboratory
9.8. Market Attractiveness Analysis
10. Middle East & Africa Antibody Discovery Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market, 2019-2023
10.3.1. By Country
10.3.2. By Method
10.3.3. By Antibody Type
10.3.4. By End User
10.4. Current Market Size (US$ Bn) and Volume (Units) Forecast By Country, 2024-2031
10.4.1. GCC
10.4.2. Egypt
10.4.3. South Africa
10.4.4. Northern Africa
10.4.5. Rest of Middle East & Africa
10.5. Current Market Size (US$ Bn) and Volume (Units) Forecast By Method, 2024-2031
10.5.1. Phage Display
10.5.2. Hybridoma
10.5.3. Others
10.6. Current Market Size (US$ Bn) and Volume (Units) Forecast By Antibody Type, 2024-2031
10.6.1. Humanized Antibody
10.6.2. Human Antibody
10.6.3. Chimeric Antibody
10.6.4. Murine Antibody
10.7. Current Market Size (US$ Bn) and Volume (Units) Forecast By End User, 2024-2031
10.7.1. Pharmaceutical and Biotechnology industry
10.7.2. Research laboratory
10.7.3. Academic laboratory
10.8. Market Attractiveness Analysis
11. Competition Landscape
11.1. Market Share Analysis, 2024
11.2. Market Structure
11.2.1. Competition Intensity Mapping By Market
11.2.2. Competition Hybridoma
11.2.3. Apparent Product Capacity
11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
11.3.1. Alcami Corporation, Inc.
11.3.1.1. Overview
11.3.1.2. Segments and Product
11.3.1.3. Key Financials
11.3.1.4. Market Developments
11.3.1.5. Market Strategy
11.3.2. BASF SE
11.3.2.1. Overview
11.3.2.2. Segments and Product
11.3.2.3. Key Financials
11.3.2.4. Market Developments
11.3.2.5. Market Strategy
11.3.3. Bioduro-Sundia
11.3.3.1. Overview
11.3.3.2. Segments and Product
11.3.3.3. Key Financials
11.3.3.4. Market Developments
11.3.3.5. Market Strategy
11.3.4. Bruker
11.3.4.1. Overview
11.3.4.2. Segments and Product
11.3.4.3. Key Financials
11.3.4.4. Market Developments
11.3.4.5. Market Strategy
11.3.5. Cambrex Corporation
11.3.5.1. Overview
11.3.5.2. Segments and Product
11.3.5.3. Key Financials
11.3.5.4. Market Developments
11.3.5.5. Market Strategy
11.3.6. Croda International Plc
11.3.6.1. Overview
11.3.6.2. Segments and Product
11.3.6.3. Key Financials
11.3.6.4. Market Developments
11.3.6.5. Market Strategy
11.3.7. Aragen Life Sciences Pvt. Ltd
11.3.7.1. Overview
11.3.7.2. Segments and Product
11.3.7.3. Key Financials
11.3.7.4. Market Developments
11.3.7.5. Market Strategy
11.3.8. Eurofins DiscoverX Corporation
11.3.8.1. Overview
11.3.8.2. Segments and Product
11.3.8.3. Key Financials
11.3.8.4. Market Developments
11.3.8.5. Market Strategy
11.3.9. NanoCellect Biomedical
11.3.9.1. Overview
11.3.9.2. Segments and Product
11.3.9.3. Key Financials
11.3.9.4. Market Developments
11.3.9.5. Market Strategy
11.3.10. Sartorius AG
11.3.10.1. Overview
11.3.10.2. Segments and Product
11.3.10.3. Key Financials
11.3.10.4. Market Developments
11.3.10.5. Market Strategy
12. Appendix
12.1. Research Methodology
12.2. Research Assumptions
12.3. Acronyms and Abbreviations